Celecoxib and bevacizumab synergistically inhibit non-small cell lung cancer by inducing apoptosis and modulating VEGF and MMP-9 expression.

Autor: Qadir A; Department of Pharmacology, United Medical and Dental College, Karachi, Pakistan., Khalid Z; Department of Physiology, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Kashan Theba F; Department of Physiology, Dow Dental College, Dow University of Health Sciences, Karachi, Pakistan., Mujtaba Ali M; Department of Pharmacology, United Medical and Dental College, Karachi, Pakistan., Asif M; Department of Pharmacology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan., Rizvi F; Department of Pharmacology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan.

Publikováno v: Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2023 Mar; Vol. 36 (2), pp. 501-506.